Chinese biotechs are trying to move beyond generic medicines and develop new drugs, under the leadership of researchers that have left Big Pharma to return to their native country.
from WSJ.com: US Business http://ift.tt/1xFwQu2
via IFTTT
from WSJ.com: US Business http://ift.tt/1xFwQu2
via IFTTT
No comments:
Post a Comment